Literature DB >> 19489581

Thermodynamics of bisphosphonates binding to human bone: a two-site model.

Sujoy Mukherjee1, Cancan Huang, Francisco Guerra, Ke Wang, Eric Oldfield.   

Abstract

We have used isothermal titration calorimetry (ITC) to study the thermodynamics of binding of 12 bisphosphonates to human bone. The ITC results show that there are two binding sites. Site A is the weak, highly populated site seen by NMR and is characterized by an average DeltaG of binding of -5.2 kcal. Site B is a strong binding site characterized by a DeltaG of binding of -8.5 kcal. Binding to both sites is overwhelmingly entropy driven. Using a thermodynamic group approach and a linear regression method, we predict the DeltaG of binding of all 12 compounds with an R(2) = 0.95 (a 0.19 kcal error variance estimate, approximately 3% of the total DeltaG range), opening up the way to designing novel chemotherapy, immunotherapy, and anti-infectious disease drugs having weak bone binding affinity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19489581      PMCID: PMC2753405          DOI: 10.1021/ja902895p

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  11 in total

1.  Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy.

Authors:  M B Martin; J S Grimley; J C Lewis; H T Heath; B N Bailey; H Kendrick; V Yardley; A Caldera; R Lira; J A Urbina; S N Moreno; R Docampo; S L Croft; E Oldfield
Journal:  J Med Chem       Date:  2001-03-15       Impact factor: 7.446

Review 2.  Bisphosphonates: from bench to bedside.

Authors:  R Graham G Russell
Journal:  Ann N Y Acad Sci       Date:  2006-04       Impact factor: 5.691

3.  Antibacterial effect of human V gamma 2V delta 2 T cells in vivo.

Authors:  L Wang; A Kamath; H Das; L Li; J F Bukowski
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

4.  Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma.

Authors:  V Kunzmann; E Bauer; J Feurle; F Weissinger; H P Tony; M Wilhelm
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

5.  Enthalpy versus entropy-driven binding of bisphosphonates to farnesyl diphosphate synthase.

Authors:  Fenglin Yin; Rong Cao; Amanda Goddard; Yonghui Zhang; Eric Oldfield
Journal:  J Am Chem Soc       Date:  2006-03-22       Impact factor: 15.419

6.  Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

Authors:  Michael Gnant; Brigitte Mlineritsch; Walter Schippinger; Gero Luschin-Ebengreuth; Sabine Pöstlberger; Christian Menzel; Raimund Jakesz; Michael Seifert; Michael Hubalek; Vesna Bjelic-Radisic; Hellmut Samonigg; Christoph Tausch; Holger Eidtmann; Günther Steger; Werner Kwasny; Peter Dubsky; Michael Fridrik; Florian Fitzal; Michael Stierer; Ernst Rücklinger; Richard Greil; C Marth
Journal:  N Engl J Med       Date:  2009-02-12       Impact factor: 91.245

Review 7.  Bisphosphonates: preclinical review.

Authors:  Jonathan R Green
Journal:  Oncologist       Date:  2004

8.  NMR investigations of the static and dynamic structures of bisphosphonates on human bone: a molecular model.

Authors:  Sujoy Mukherjee; Yongcheng Song; Eric Oldfield
Journal:  J Am Chem Soc       Date:  2008-01-04       Impact factor: 15.419

9.  Radical cure of experimental cutaneous leishmaniasis by the bisphosphonate pamidronate.

Authors:  Noris Rodriguez; Brian N Bailey; Michael B Martin; Eric Oldfield; Julio A Urbina; Roberto Docampo
Journal:  J Infect Dis       Date:  2002-06-05       Impact factor: 5.226

10.  Lipophilic bisphosphonates as dual farnesyl/geranylgeranyl diphosphate synthase inhibitors: an X-ray and NMR investigation.

Authors:  Yonghui Zhang; Rong Cao; Fenglin Yin; Michael P Hudock; Rey-Ting Guo; Kilannin Krysiak; Sujoy Mukherjee; Yi-Gui Gao; Howard Robinson; Yongcheng Song; Joo Hwan No; Kyle Bergan; Annette Leon; Lauren Cass; Amanda Goddard; Ting-Kai Chang; Fu-Yang Lin; Ermond Van Beek; Socrates Papapoulos; Andrew H-J Wang; Tadahiko Kubo; Mitsuo Ochi; Dushyant Mukkamala; Eric Oldfield
Journal:  J Am Chem Soc       Date:  2009-04-15       Impact factor: 15.419

View more
  22 in total

1.  Polyoxometalates functionalized by bisphosphonate ligands: synthesis, structural, magnetic, and spectroscopic characterizations and activity on tumor cell lines.

Authors:  Hani El Moll; Wei Zhu; Eric Oldfield; L Marleny Rodriguez-Albelo; Pierre Mialane; Jérôme Marrot; Neus Vila; Israel Martyr Mbomekallé; Eric Rivière; Carole Duboc; Anne Dolbecq
Journal:  Inorg Chem       Date:  2012-06-22       Impact factor: 5.165

2.  Anticancer Activity of Polyoxometalate-Bisphosphonate Complexes: Synthesis, Characterization, In Vitro and In Vivo Results.

Authors:  Amandine Boulmier; Xinxin Feng; Olivier Oms; Pierre Mialane; Eric Rivière; Christopher J Shin; Jiaqi Yao; Tadahiko Kubo; Taisuke Furuta; Eric Oldfield; Anne Dolbecq
Journal:  Inorg Chem       Date:  2017-06-20       Impact factor: 5.165

Review 3.  Targeting polymer therapeutics to bone.

Authors:  Stewart A Low; Jindřich Kopeček
Journal:  Adv Drug Deliv Rev       Date:  2012-01-28       Impact factor: 15.470

4.  Biocompatible inorganic nanoparticles for [18F]-fluoride binding with applications in PET imaging.

Authors:  Maite Jauregui-Osoro; Peter A Williamson; Arnaud Glaria; Kavitha Sunassee; Putthiporn Charoenphun; Mark A Green; Gregory E D Mullen; Philip J Blower
Journal:  Dalton Trans       Date:  2011-03-11       Impact factor: 4.390

Review 5.  [Research progress on the biomimetic remineralization of hard tooth tissues based on polyamide-amine dendrimer].

Authors:  Ke-Zhen Xiang; Liang Chen; De-Qin Yang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-12-01

6.  Low-energy conformers of pamidronate and their intramolecular hydrogen bonds: a DFT and QTAIM study.

Authors:  Masoud Arabieh; Mohammad Hossein Karimi-Jafari; Mohammad Ghannadi-Maragheh
Journal:  J Mol Model       Date:  2012-09-02       Impact factor: 1.810

7.  Lipophilic analogs of zoledronate and risedronate inhibit Plasmodium geranylgeranyl diphosphate synthase (GGPPS) and exhibit potent antimalarial activity.

Authors:  Joo Hwan No; Fernando de Macedo Dossin; Yonghui Zhang; Yi-Liang Liu; Wei Zhu; Xinxin Feng; Jinyoung Anny Yoo; Eunhae Lee; Ke Wang; Raymond Hui; Lucio H Freitas-Junior; Eric Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-05       Impact factor: 11.205

8.  Isoprenoid Biosynthesis Inhibitors Targeting Bacterial Cell Growth.

Authors:  Janish Desai; Yang Wang; Ke Wang; Satish R Malwal; Eric Oldfield
Journal:  ChemMedChem       Date:  2016-08-30       Impact factor: 3.466

9.  Chemo-Immunotherapeutic Anti-Malarials Targeting Isoprenoid Biosynthesis.

Authors:  Yonghui Zhang; Wei Zhu; Yi-Liang Liu; Hong Wang; Ke Wang; Kai Li; Joo Hwan No; Lawrence Ayong; Anmol Gulati; Ran Pang; Lucio Freitas-Junior; Craig T Morita; Eric Old-Field
Journal:  ACS Med Chem Lett       Date:  2013-04-11       Impact factor: 4.345

10.  Synthesis, solution, and structural characterization of tetrahydrofuranyl-2,2-bisphosphonic acid disodium salt.

Authors:  Elena Maltezou; Marios Stylianou; Sudeshna Roy; Chryssoula Drouza; Anastasios D Keramidas
Journal:  Bioinorg Chem Appl       Date:  2010-05-11       Impact factor: 7.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.